c-myc as a mediator of accelerated apoptosis and involution in mammary glands lacking Socs3

被引:43
作者
Sutherland, Kate D.
Vaillant, Francois
Alexander, Warren S.
Wintermantel, Tim M.
Forrest, Natasha C.
Holroyd, Sheridan L.
McManus, Edward J.
Schutz, Gunther
Watson, Christine J.
Chodosh, Lewis A.
Lindeman, Geoffrey J.
Visvader, Jane E.
机构
[1] Walter & Eliza Hall Inst Med Res, VBCRC Lab, Parkville, Vic 3050, Australia
[2] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia
[3] Walter & Eliza Hall Inst Med Res, Canc & Haematol Div, Parkville, Vic 3050, Australia
[4] German Canc Res Ctr, D-6900 Heidelberg, Germany
[5] Univ Cambridge, Mammary Apoptosis & Dev Grp, Dept Pathol, Cambridge, England
[6] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA
关键词
apoptosis; c-myc; mammary; Socs3; Stat3;
D O I
10.1038/sj.emboj.7601455
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Suppressor of cytokine signalling (SOCS) proteins are critical attenuators of cytokine-mediated signalling in diverse tissues. To determine the importance of Socs3 in mammary development, we generated mice in which Socs3 was deleted in mammary epithelial cells. No overt phenotype was evident during pregnancy and lactation, indicating that Socs3 is not a key physiological regulator of prolactin signalling. However, Socs3-deficient mammary glands exhibited a profound increase in epithelial apoptosis and tissue remodelling, resulting in precocious involution. This phenotype was accompanied by augmented Stat3 activation and a marked increase in the level of c-myc. Moreover, induction of c-myc before weaning using an inducible transgenic model recapitulated the Socs3 phenotype, and elevated expression of likely c-myc target genes, E2F-1, Bax and p53, was observed. Our data establish Socs3 as a critical attenuator of pro-apoptotic pathways that act in the developing mammary gland and provide evidence that c-myc regulates apoptosis during involution.
引用
收藏
页码:5805 / 5815
页数:11
相关论文
共 61 条
[21]   A dual, non-redundant, role for LIF as a regulator of development and STAT3-mediated cell death in mammary gland [J].
Kritikou, EA ;
Sharkey, A ;
Abell, K ;
Came, PJ ;
Anderson, E ;
Clarkson, RWE ;
Watson, CJ .
DEVELOPMENT, 2003, 130 (15) :3459-3468
[22]   Suppressors of cytokine signaling and immunity [J].
Kubo, M ;
Hanada, T ;
Yoshimura, A .
NATURE IMMUNOLOGY, 2003, 4 (12) :1169-1176
[23]   Selective involvement of TIMP-2 in the second activational cleavage of pro-MMP-2: refinement of the pro-MMP-2 activation mechanism [J].
Lafleur, MA ;
Tester, AM ;
Thompson, EW .
FEBS LETTERS, 2003, 553 (03) :457-463
[24]  
Lafleur Marc A, 2003, Expert Rev Mol Med, V5, P1, DOI 10.1017/S1462399403006628
[25]   SOCS3 regulates the plasticity of gp130 signaling [J].
Lang, R ;
Pauleau, AL ;
Parganas, E ;
Takahashi, Y ;
Mages, J ;
Ihle, JN ;
Rutschman, R ;
Murray, PJ .
NATURE IMMUNOLOGY, 2003, 4 (06) :546-550
[26]   Mammary-derived signals activate programmed cell death during the first stage of mammary gland involution [J].
Li, ML ;
Liu, XW ;
Robinson, G ;
BarPeled, U ;
Wagner, KU ;
Young, WS ;
Hennighausen, L ;
Furth, PA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (07) :3425-3430
[27]   SOCS1 deficiency results in accelerated mammary gland development and rescues lactation in prolactin receptor-deficient mice [J].
Lindeman, GJ ;
Wittlin, S ;
Lada, H ;
Naylor, MJ ;
Santamaria, M ;
Zhang, JG ;
Starr, R ;
Hilton, DJ ;
Alexander, WS ;
Ormandy, CJ ;
Visvader, J .
GENES & DEVELOPMENT, 2001, 15 (13) :1631-1636
[28]   Activation of Stat5a and Stat5b by tyrosine phosphorylation is tightly linked to mammary gland differentiation [J].
Liu, XW ;
Robinson, GW ;
Hennighausen, L .
MOLECULAR ENDOCRINOLOGY, 1996, 10 (12) :1496-1506
[29]  
Lund LR, 1996, DEVELOPMENT, V122, P181
[30]   SOCS3 is essential in the regulation of fetal liver erythropoiesis [J].
Marine, JC ;
McKay, C ;
Wang, DM ;
Topham, DJ ;
Parganas, E ;
Nakajima, H ;
Pendeville, H ;
Yasukawa, H ;
Sasaki, A ;
Yoshimura, A ;
Ihle, JN .
CELL, 1999, 98 (05) :617-627